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General and specific severity scores for patients with acute
kidney injury have significant limitations due in part to the
diversity of methods that have been used. Here we
prospectively validated five general (APACHE II, SAPS II,
SOFA, LODS, and OSF) and three specific (SHARF, Lian˜o, and
Mehta) scoring systems in 366 critically ill patients who
developed acute kidney injury in the intensive care unit.
Sequential scores in each system were determined on the
day that acute kidney injury was diagnosed, on the day when
acute kidney injury–specific score criteria were achieved, and
on the day of initial nephrology consultation. Acute kidney
injury, defined as an increase of 50% or more in the baseline
serum creatinine, was mainly due to sepsis, and had an
incidence of 19% and an overall 68% mortality. A progressive
improvement in score performance was found. On the day of
initial nephrology consultation, most scores showed a good
performance and two indices (SAPS II and SHARF) achieved
an area under the receiver operating characteristic curve
above 0.80. Calibration was good on all three defining days,
except for OSF when score criteria were achieved, and Mehta
at the time of nephrology consultation. Our study shows that
early and sequential evaluation is a better approach for
prognostic scoring in critically ill patients who develop acute
kidney injury.
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Both general and specific scores have been applied to acute
kidney injury (AKI) patients, particularly in the intensive
care unit (ICU). The main objectives are to provide survival
prediction and an accurate stratification of the severity of
patients’ illness for clinical studies, and evaluation of
therapeutic interventions.1 Currently, there are no universal,
validated, and accepted scoring systems for AKI patients.2
Studies have presented conflicting results due to difficulties
such as variations in AKI definitions and the use of
heterogeneous populations with different mortality rates,
leading to significant limitations.3
AKI is frequently associated with multiple organ dysfunc-
tion syndrome, which affects critically ill patients. Therefore,
to better assess the influence of dynamic physiological
variables and the effects of therapeutic interventions, long-
itudinal or sequential prognostic evaluations seem to be the
most appropriate approach.4
In this study, a model of sequential and prospective
evaluation of five general and three AKI-specific scores in
critically ill patients was evaluated. We hypothesized that
using a less strict definition of AKI could also improve the
performance of severity scores and allow for better use of
prognostic models starting at earlier stages of AKI.
RESULTS
A total of 2998 patients were admitted to the selected ICUs.
The final sample size comprised 366 patients (Figure 1).
The AKI incidence was 19% (400 out of 2096 patients).
Sepsis was the main cause of AKI (67%) and overall mortality
was 67.8%. Nephrology consultations were requested by the
ICU team for only 196 patients (53.5%) (Table 1).
Specific AKI scores criteria were met 1 day on average
(0–2) after the AKI diagnosis day (D0), and this day was
marked as D1. Nephrology consultations occurred 3 days1–4
after D0, and this was marked D3. Table 2 shows clinical and
laboratory data for the 3 days of analysis.
SAPS II (Simplified Acute Physiology Score II) was the
general score with the best performance on all assessed days.
The specific score with the best performance was SHARF
(Stuivenberg Hospital Acute Renal Failure), followed by the
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Lian˜o score (Table 3). A progressive improvement in scores’
performance was seen. On D0, only SAPS II and SHARF
scores presented satisfactory discrimination. On D1, these
two indices and an additional three scores (Acute Physiology
and Chronic Health Evaluation II, Sequential Organ
Failure Assessment, and Lian˜o) reached the discriminatory
threshold. On D3, all scores except Mehta presented good
performance and two indices (SAPS II and SHARF) achieved
an AUROC (area under the receiver operating characteristic
curve) above 0.80. Calibration was good for all scores on all 3
days, except for Organ System Failure on D1 and Mehta on
D3. Figures 2 and 3 show the discrimination and calibration
curves for SAPS II and SHARF scores on all days of analysis.
DISCUSSION
This study shows a dynamic aspect for the prognostic scores
in critically ill AKI patients. AKI is an inflammatory disease
that usually comprises a multiple organ dysfunction
syndrome that affects severely ill patients. These patients
receive many therapeutic interventions (fluid resuscitation,
antibiotics therapy, mechanical ventilation, nutritional sup-
port, glycemic control, etc.) with varying clinical responses. A
great variation in physiological parameters and organ failure
is expected. Our results clearly show the importance of
assessing AKI as a dynamic and progressive process in which
patients’ assessments at any single moment may be
inadequate. Another important aspect was the utilization of
a less strict AKI definition, allowing for evaluation at
earlier stages of the disease. Consequently, models provided
for better performance since the beginning of the follow-up
and prognostic scores achieved higher discriminatory accu-
racy compared with most earlier studies.4–7 The PICARD
study was the only one in which a similar sequential
prospective evaluation was performed. However, that study
reported unsatisfactory scores’ performances, probably due
to the utilization of a more strict AKI definition and
population heterogeneity because of the multicenter nature
of the study.
In this study, other factors may have contributed to the
good scores’ performances. Patients were evaluated by only
one observer in a single academic institution. Additionally,
only cases with presumed clinical acute tubular necrosis were
enrolled and sepsis was found in about 70% of the sample,
resulting in a more homogeneous population. In addition,
only 8.5% of the patients were excluded (missing data),
minimizing the risk of selection and analysis bias.
Furthermore, our hospital is a tertiary assistance institu-
tion and is a reference hospital for medical assistance and
research, receiving mostly severely ill patients. On the other
hand, this effect may have been partially minimized by the
better care provided to these patients compared with other
non-academic institutions.
In conclusion, general and specific scores with the best
performance on all days of analysis were SAPS II and SHARF,
respectively. Sequential and early evaluation seems to be a
better approach for prognostic scoring systems in critically ill
AKI patients.
PATIENTS AND METHODS
A prospective observational study was conducted through an
active search for AKI cases by daily visits to six ICUs
2998 Patients
were admitted
2096 Patients
582 AKI patients 182 Patients were excluded:
 160 Pre-renal AKI
 22  Obstructive or other intrinsic AKI
400 Patients with
presumed ATN
Final sample size
366 patients
34 Missing data
902 Patients were excluded:
 232  Chronic renal failure or transplanted
 92 Under 18 years of age
 428  ICU stay shorter than 48 h
 150 With AKI diagnosis over 24 h before ICU admission
Figure 1 | Study population – a total of 2998 patients were
admitted in the selected ICUs (intensive care units), resulting
in a final sample of 366 patients with presumed ATN (acute
tubular necrosis).
Table 1 | Patients’ baseline characteristics
Variable n %
Demographic
Age X60 (years) 182 49.7
Men 216 59
Race/ethnicity
Caucasian 253 69.1
African American 16 4.4
Asian 5 1.4
Mixed 92 25.1
Comorbidity
CKD (stage III or above) 87 23
Hypertension 152 41.5
Heart failure 69 18.9
Coronary disease 28 7.7
Stroke 25 6.8
Peripheral vascular disease 13 3.6
Diabetes mellitus 85 23.2
COPD 24 6.6
Solid tumor 85 23.2
Leukemia/lymphoma 23 6.3
Liver disease 20 5.5
HIV positive 24 6.6
Clinical
Sepsis 244 66.7
Nephrology consultation 196 53.5
Dialysis therapy 112 30.6
CKD, chronic kidney dysfunction; COPD, chronic obstructive pulmonary disease; HIV,
human immunodeficiency virus.
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(Pneumology, Surgery, Trauma, Emergency, Internal medi-
cine, and Infectious diseases), comprising 53 beds, in the
University of Sa˜o Paulo School of Medicine, Brazil. This
hospital is a tertiary academic institution with 13 ICUs,
totaling 128 beds. The study protocol was approved by the
local ethics committee and an informed consent was not
required.
Study population
All patients admitted to the selected ICUs were evaluated for
renal function between November 2003 and June 2005. AKI
was defined as an increase of X50% on baseline serum
creatinine. Only AKI cases diagnosed in the ICU or within
the 24 h of admission were included. The exclusion criteria
were baseline serum creatinine X3.0 mg/100 ml, previous
dialysis, ageo18 years, kidney transplantation, and ICU stay
for lesser than 48 h. Only cases of presumed acute tubular
necrosis were considered. Sepsis was diagnosed according to
established criteria.8 Chronic kidney dysfunction was con-
sidered if an estimated creatinine clearance o60 ml/min per
1.73 m2 was present (NKF (National Kidney Foundation)
stageXIII).
Data variables
The collected variables were age, gender, race, hospital and
ICU admission days, ICU origin, comorbidities, baseline
renal function, presumed etiologies of AKI, vital signs, urine
output, clinical events (sepsis, hypovolemia, bleeding, low
cardiac output, cardiac arrest), laboratory studies, diagnostic
and therapeutic procedures, including medications in use,
nutritional support, vasoactive drugs, and mechanical
ventilation. Multiple generic scores – Organ System Failure,9
Table 2 | Patients’ characteristics on the day of AKI diagnosis (D0), the day when specific score criteria were met (D1), and the
day of nephrology consultation (D3)
D0 D1 D3
Parameter Variable (N=366) (N=366) (N=366)
Organ failure Number of organ failures 3.0 (2.0–4.0) 3.0 (1.0–3,0) 2.0 (1.0–3.0)*
% CNS failure 47.8 50.9* 50*,w
% Liver failure 50 52.8 49.2*
% Cardiovascular failure 74.3 60.4 43.3*,w
% Hematologic failure 9 10.8* 12*,w
% Respiratory failure 73.8 74.7* 77.3*,w
% Acute lung injury 72.4 72.5* 66.7*
% ARDS 32.2 33.9* 30.1*,w
Physiological variables Heart rate (per min) 100±19 100±17 98±18*
% Tachycardia 73 76* 73.8*,w
Systolic BP (mm Hg) 120 (108–133) 121 (110–135) 127 (113–141)*
Diastolic BP (mm Hg) 67 (60–75) 70 (60–76) 70 (62–80)*
Mean arterial BP (mm Hg) 85 (77–93) 87 (78–96) 89 (80–99)*,w
Temperature (1C) 36.5 (36–37) 36.5 (36–37) 36.5 (36–37)
Urine output (ml/24 h) 1005 (523–1665) 945 (450–1570) 1030 (380–2000)
% Oliguria (o400 ml/day) 18.6 22.5* 25.1
% Furosemide use 25.1 24.9* 30.3*,w
Respiratory rate 18 (14–23) 18 (14–23) 19 (15–23)
Laboratory variables aAO2 149 (98–197) 148 (95–204) 127 (81–164)*,w
Creatinine (mg/100 ml) 1.9 (1.5–2,6) 2.3 (2.0–3.0) 2.4 (1.6–3.5)*,w
Urea (mg/100 ml) 74 (50–108) 93 (70–115) 98 (63–143)*,w
pH 7.32 (7.24–7.39) 7.32 (7.24–7.38) 7.33 (7.25–7.39)
Bicarbonate (mEq/l) 17 (14–20) 16 (13–19)* 16 (14–20)
Lactate (mmol/100 ml) 19 (13–26) 19 (12–27) 17 (13–23)w
Potassium (mEq/l) 4.4 (3.8–5.1) 4.6 (3.9–5.3) 4.4 (3.7–5.1)w
Sodium (mEq/l) 140 (136–144) 141 (136–145) 142 (137–145)*
Leukocyte (1000/mm3) 13.3 (9.0–19.0) 13.4 (9.0–18.8) 12.3 (8.4–18.8)
Platelets (1000/mm3) 168 (101–274) 158 (90–253)* 151 (85–236)*
% Thrombocytopenia
(o150, 000 platelets/mm3)
43.4 42.1* 49.7
Hematocrit (%) 29 (26–34) 29 (26–34) 28 (24–32)*,w
Total bilirubin (mg/100 ml) 0.8 (0.4–2.0) 0.8 (0.5–2.5) 0.8 (0.5–2.0)
Enzymatic activity (%) 52±22 50±21 49±24*
GPT (UI/100 ml) 26 (16–62) 25 (14–61) 25 (13–55)*
GOT (UI/100 ml) 42 (24–98) 43 (23–100) 39 (23–79)w
Albumin (g/100 ml) 2.1 (1.8–2.6) 2.1 (1.7–2.5) 2.1 (1.7–2.6)*
aAO2, alveolar–arterial oxygen difference; ARDS, adult respiratory distress syndrome; BP, blood pressure; CNS, central nervous system; GOT, aspartate aminotransferases; GPT,
alanine aminotransferases.
*Po0.05 vs D0.
wPo0.05 vs D1.
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Acute Physiology and Chronic Health Evaluation II,10 SAPS
II,11 Sequential Organ Failure Assessment,12 Logistic Organ
Dysfunction Score13– and AKI-specific severity scores –
SHARF,14 Lian˜o,15 and Mehta1 – were calculated. Organ
failure was defined as (a) respiratory – need of mechanical
ventilation; (b) central nervous system – Glasgow scale p8;
(c) hepatic – total bilirubin X2.0 mg/100 ml and/or enzy-
matic activityp50%; (d) hematological – leukocytesp1000/
mm3 and/or platelets p20, 000 and/or hematocrit p20%;
(e) cardiovascular – cardiovascular Sequential Organ Failure
Assessment score X3.
Data collection strategy
Data were collected on the D0, D1, and D3. All patients were
followed until hospital discharge or death. In-hospital
mortality was the primary outcome. Data were collected
by an observer not part of the ICU or nephrology
staff. Nephrology consultation was solicited by the ICU
physician.
Statistical analysis
All 366 patients (either referred or not referred to a
nephrologist) were sequentially evaluated. The Kolmogor-
ov–Smirnov normality test was applied for continuous and
semi-continuous variables. Data with normal distributions
are expressed as mean±s.d. and were compared with an
ANOVA (analysis of variance) test for repeated measures with
Newman–Keuls post-test. Continuous variables without
normal distribution are expressed as medians with 25th
and 75th quartiles and were analyzed with the Friedmann test
with a Mu¨ller–Dunn post-test. Categorical variables are
expressed as proportions and were analyzed with Pearson’s
w2 test for independent groups and compared with the
McNemar test. The discrimination of scores was assessed
using the AUROC. Calibration was assessed using the
Hosmer–Lemeshow goodness-of-fit test comparing observed
vs expected mortality across deciles of risk. Two-tailed
P-values o0.05 were considered significant. Statistical
analysis was carried out by SPSS for Windows version 13.0
(Chicago, IL, USA).
Table 3 | Score values and area under the receiver operating
characteristic (AUROC) curves for scoring systems on the day
of AKI diagnosis (D0), the day when specific score criteria
were met (D1), and the day of nephrology consultation (D3)
Scores D0 D1 D3
Score values
APACHE II 26.4±7.0 27.5±6.8* 27.9±7.4*
SAPS II 53.0±17.5 55.4±17.3* 55.4±19.2*
LODS 8.0 (6.0–10.0) 8.0 (6.0–10.0) 9.0 (6.0–11.0)*
OSF 3.0 (2.0–3.0) 3.0 (2.0–3.0) 3.0 (2.0–3.0)
SOFA 10.0 (7.0–13.0) 10.0 (7.0–12.0) 11.0 (8.0–14.0)*,w
SHARF 181 (158–198) 180 (158–195)* 183 (161–198)w
Mehta 3.13 (2.29–4.37) 3.55 (2.69–4.44)* 3.74 (2.57–5.31)*
Lian˜o 0.49±0.18 0.51±0.18 0.48±0.19w
AUROC
APACHE II 0.66±0.029 0.70±0.031 0.77±0.025*
SAPS II 0.73±0.028 0.76±0.030 0.83±0.022*,w
LODS 0.63±0.031 0.67±0.033 0.79±0.024*,w
OSF 0.64±0.032 0.65±0.035 0.71±0.030*,w
SOFA 0.68±0.030 0.70±0.032 0.74±0.027
SHARF 0.71±0.031 0.75±0.029 0.81±0.026y
Mehta 0.51±0.036z 0.57±0.037 0.63±0.035z
Lian˜o 0.67±0.034 0.71±0.032 0.77±0.029**
APACHE, Acute Physiology and Chronic Health Evaluation; LODS, Logistic Organ
Dysfunction Score; OSF, Organ System Failure; SAPS, Simplified Acute Physiology
Score; SHARF, Stuivenberg Hospital Acute Renal Failure; SOFA, Sequential Organ
Failure Assessment.
*Po0.05 vs D0.
wPo0.05 vs D1.
zAsymptotic P=not significant.
yP=0.07.
zP=0.051.
**P=0.08.
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Figure 2 | Area under the ROC (receiver operating
characteristic) curve (AUROC) and calibration curve for SHARF
(Stuivenberg Hospital Acute Renal Failure) score on the day
of AKI (acute kidney injury) diagnosis (D0), the day when
specific score criteria were met (D1), and the day of
nephrology consultation (D3).
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Figure 3 | Area under the ROC (receiver operating
characteristic) curve (AUROC) and calibration curve for SAPS II
(Simplified Acute Physiology Score II) score on the day of AKI
(acute kidney injury) diagnosis (D0), the day when specific
score criteria were met (D1), and the day of nephrology
consultation (D3).
986 Kidney International (2009) 75, 982–986
t e c h n i c a l n o t e s VT Costa e Silva et al.: Sequential evaluation of prognostic models in AKI
